drugset / Trial / NCT00998686
Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to demonstrate the safety and tolerability of dutogliptin over 52 weeks.
Timeline
- Start
- 2009-11
- Primary completion
- 2011-10
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dutogliptin | Small molecule | 400 mg | — |
| Comparator | Sitagliptin | Small molecule | 100 mg | — |